Interventional oncology procedures involve the diagnosis and treatment of cancer and cancer-related problems by using minimally invasive (MI) procedures performed under image guidance. Interventional oncology uses X-ray, ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI) to guide accessories and instruments, such as ablation electrodes, biopsy needles, guidewires, and intravascular catheters that allow the treatment of a tumor located in some part of the body. Interventional oncology treatments are regularly carried out by interventional radiologists with appropriate settings and facilities. Interventional oncology is used to treat primary or metastatic cancer, which includes liver cancer, lung cancer, kidney cancer, bone cancer, breast cancer, and prostate and pancreatic cancer.

PART 01: Executive summary

PART 02: Scope of the report

Market overview

Top-vendor offerings

Research methodology

PART 03: Market research methodology

Economic indicators

PART 04: Introduction

Key market highlights

Market overview

PART 05: Market landscape

Five force analysis

PART 06: Market segmentation by procedure

Ablation

Global interventional oncology ablation market

Embolization

Global interventional oncology embolization market

PART 07: Geographical segmentation

Interventional oncology market in Americas

Interventional oncology market in EMEA

Interventional oncology market in APAC

Growing cancer population

PART 08: Market drivers

Growing R&D activities

Advances in technology

Growing demand for MI procedures

PART 09: Impact of drivers

PART 10: Market challenges

Risks associated with interventional oncology procedures

High cost of interventional oncology procedures

Presence of alternatives

Limited skilled practitioners

PART 11: Impact of drivers and challenges

PART 12: Market trends

Growing integration of image-guided solutions with interventional oncology procedures

Increasing inorganic growth strategies by vendors

Growing focus toward the adoption of MWA

Growing adoption of SIRT and HIFU

Competitive scenario

PART 13: Vendor landscape

Key news

Mergers and acquisitions

PART 14: Key vendor analysis

Boston Scientific

BTG

Medtronic

Merit Medical

TERUMO CORPORATION

Other prominent vendors

PART 15: Appendix

List of abbreviations

PART 16: Explore Technavio